Anthony Cino is a Senior Vice President at ASG, where he leads the firm’s work supporting health and life science clients around the world. He also serves as a member of the firm’s Asia practice, bringing more than 12 years of experience working with China and other East Asian markets to assist clients in the region.
Prior to joining the firm, Mr. Cino was an Associate Vice President for International Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), the world’s leading trade association for the innovative pharmaceutical industry. While at PhRMA, Mr. Cino led government affairs and partnership activity in China, Southeast Asia, and New Zealand. His responsibilities included strategic planning, messaging, government outreach, and partnership and alliance development. Additionally, Mr. Cino supported PhRMA’s global coordination on biotechnology policy matters.
Previously, he spent four years at the U.S. Department of Commerce’s International Trade Administration (ITA), where he worked to maximize market access for U.S. healthcare and financial service companies in China and monitored China’s compliance with global trade commitments in those sectors. During his tenure at ITA, Mr. Cino served at the U.S. Embassy in Beijing, and as ITA’s working-level lead on two major bilateral dialogues, the U.S.-China Strategic and Economic Dialogue and the Joint Commission on Commerce and Trade. Prior to his time in government, Mr. Cino was an Analyst in New York for an energy-oriented private equity firm.
Mr. Cino completed his M.A. in International Affairs with a focus on East Asia at Columbia University’s School of International and Public Affairs and holds a B.A. in International Studies and Economic Theory from American University.
He is proficient in Mandarin Chinese.
Mr. Cino is based in Washington, DC.